Product
21.15.GPC3-CAR T cells
1 clinical trial
8 indications
Indication
hepatoblastomaIndication
Hepatocellular CarcinomaIndication
Wilms tumorIndication
Malignant Rhabdoid TumorIndication
yolk sac tumorIndication
RhabdomyosarcomaIndication
LiposarcomaIndication
HepatoblastomaClinical trial
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using Interleukin-15 And -21 Armored Glypican-3-Specific Chimeric Antigen Receptor Expressing Autologous T CellsStatus: Not yet recruiting, Estimated PCD: 2028-02-01